Condition
Vasopressor Adverse Reaction
Total Trials
3
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06422975Recruiting
Registry of Patients in Shock Treated With Vasopressin
NCT05411315Not ApplicableCompleted
Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
NCT06163352Not ApplicableCompletedPrimary
The Effect of Vasopressor on Pressure Injury Development
Showing all 3 trials